ArticleJournal of experimental & clinical cancer research : CR2026

Combinatorial inhibition of IGF2BP3-regulated receptor tyrosine kinases offers a new therapeutic strategy for triple-negative breast cancer.

Zi-Wen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.